<p><strong>Bleeding</strong>: Dabigatran Etexilate can cause serious and fatal bleeding<br />
<br />
<strong>Bioprosthetic heart valves</strong>: Dabigatran Etexilate use not recommended<br />
<br />
<strong>Increased Risk of Thrombosis in Patients with Triple-Positive Antiphospholipid Syndrome</strong>: Dabigatran Etexilate use not recommended</p>